Because pheo and para are rare, it is essential to be your own best advocate. The
KnowPheoPara video learning center is a growing collection of media and learning
resources to help you become better equipped to do just that.
Pheo and Para: A Disease Like None Other
Follow Dave Bassham, a person with pheochromocytoma, and endocrinologist Dr. Joseph
Dillon in this short documentary about Dave's experience living with pheochromocytoma,
getting diagnosed and treated, and facing disease recurrence. The documentary aired as
part of Lifetime's "The Balancing Act" TV series on Rare Disease Day 2019.
Lenders JWM, et al. Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology & Metabolism 2014; 99(6):1915–1942 doi:10.1210/jc.2014-1498. Reproduced with permission of Oxford University Press on behalf of the Endocrine Society. Please visit: https://academic.oup.com/jcem/article/99/6/1915/2537399. Progenics Pharmaceuticals was not involved in the development of the Endocrine Society Guidelines and in no way influenced its content.
Lefebvre M, Foulkes WD. Curr Oncol. 2014;21(1):e8-e17.
Whalen R, et al. G. J Urol. 1992;147(1):1-10.
Gunawardane PTK, Grossman A. Adv Exp Med Biol. 2017;956:239-259.
Ilias I, Pacak K. Nucl Med Biol. 2008;35 Suppl 1:S27-S34.
Scholz T, et al. J Clin Endocrinol Metab. 2007;92(4):1217-1225.
Engelman K. Bull N Y Acad Med. 1969;45(9):851-858.
Jimenez C, et al. Curr Oncol Rep. 2013;15(4):356-371.
Eisenhofer G, et al. Endocr Relat Cancer. 2004;11:423-436.
Ayala-Ramirez M, et al. J Clin Endocrinol Metab. 2012;97(11):4040-4050.
Amar L, et al. Horm Metab Res. 2012;44(5):385-389.
Kerr D. Oxford Textbook of Oncology; 2016.
Martucci VL, Pacak K. Curr Probl Cancer. 2014;38(1):7-41.
US Census Bureau. US and World Population Clock. https://www.census.gov/popclock/. Accessed October 1, 2017.
Chen H, et al. Pancreas. 2010;39(6):775-783.
American Cancer Society. Cancer Facts & Figures 2017; 2017.
Kirmani S, Young W. 2014.
Beard CM, et al. Mayo Clin Proc. 1983;58(12):802-804.
Fishbein L. Hematol Oncol Clin North Am. 2016;30(1):135-150.
Baudin E, et al. Eur J Endocrinol. 2014;171(3):R111-R1122.
Phan A. Case-Based Discussion- Systemic Therapies for Advanced PHEO and PGL. In: European Society for Medical Oncology (ESMO) Congress 2014; September 26-30, 2014; Madrid, Spain.
Pacak, K. Clin. Endocrinol. Metab. 92(11):4069-4079.
Beilan JA, et al. BMC Urol. 2013;13(22):1-6.
Mannelli M, et al. Best Pract Res Clin Endocrinol Metab. 2012; 26(4):507-515.
Kantorovich V, Pacak K. Prog Brain Res. 2010;182:343-373.
Zuber SM, et al. Endocrinol Metab Clin North Am. 2011;40(2):295-311.